Related Experiment Video
Updated: Oct 4, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.5K
Microarray-based differential expression profiling of long noncoding RNAs and messenger RNAs in formalin-fixed
Hui-Xian Yan1,2, Jin Du1, Jing Fu3
1Department and Key Laboratory of Endocrinology and Metabolism, PLA General Hospital, Beijing 100853, China.
Translational Cancer Research
|February 4, 2022
Summary
This study identified novel long noncoding RNAs (lncRNAs) associated with papillary thyroid carcinoma (PTC). Further research into these lncRNAs may lead to improved PTC diagnosis and treatment strategies.
Area of Science:
- Molecular Biology
- Genomics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) regulate gene expression and are implicated in various cancers.
- The role of lncRNAs in papillary thyroid carcinoma (PTC) remains largely unexplored.
Purpose of the Study:
- To identify novel lncRNAs involved in the development of papillary thyroid carcinoma (PTC).
- To explore the potential diagnostic and therapeutic implications of these lncRNAs in PTC.
Main Methods:
- Microarray analysis of mRNA and lncRNA expression in PTC and nodular goiter tissues.
- Quantitative polymerase chain reaction (q-PCR) for validation of differentially expressed genes.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
- Co-expression analysis to identify regulatory relationships between lncRNAs and target genes.
Main Results:
- Aberrant expression of 94 lncRNAs and 99 mRNAs was observed in PTC tissues compared to nodular goiter.
- Microarray findings were validated using q-PCR.
- Co-expression analysis highlighted the association of lncRNAs n382996, n342483, and n409114 with the regulation of MT1G, MT1H, and MT1F.
Conclusions:
- Novel lncRNAs associated with PTC have been identified.
- These findings suggest potential roles for specific lncRNAs in PTC pathogenesis.
- Further investigation is warranted to explore the diagnostic and therapeutic potential of these novel lncRNAs in PTC.

